Device
paclitaxel-coated balloon
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(25%)
Phase Distribution
Ph phase_4
1
25%
Ph not_applicable
2
50%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Terminated(2)
Other(1)
Detailed Status
Terminated1
Not yet recruiting1
Withdrawn1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
terminated125%
not_yet_recruiting125%
withdrawn125%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Biolimus-Coated Balloon in de Novo Large Vessel Coronary Lesions
NCT06669793
unknownnot_applicable
PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)
NCT03155971
withdrawnphase_3
Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis
NCT01398033
terminatedphase_4
A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR)
NCT01204320
Clinical Trials (4)
Showing 4 of 4 trials
NCT06669793Not Applicable
Biolimus-Coated Balloon in de Novo Large Vessel Coronary Lesions
NCT03155971Not Applicable
PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)
NCT01398033Phase 3
Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis
NCT01204320Phase 4
A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR)
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4